Actuate Therapeutics ACTU
NASDAQ ACTU
$0.71 +0.02 (+3.47%)
As of: Sep 30, 2026 · 10:23 AM EDT

Actuate Therapeutics (ACTU) Assets (2023 - 2026)

Updated

Actuate Therapeutics (ACTU) recorded Assets of $5.2 million in Q2 2026, down 25.4% from $6.97 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Actuate Therapeutics reported Assets of $14.04 million, up 50.6% from FY2024.

  • Across earlier years, Assets came in at $9.32 million in FY2024 (+211.1%) and $3 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Assets since Q1 2025.
  • On a year-over-year basis, Assets rose in four of the last five quarters, with growth averaging 112.6%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Actuate Therapeutics 17.77 Mn 17.77 Mn - 5.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.20 Mn
Dec 31, 2025 14.04 Mn
Sep 30, 2025 17.71 Mn
Jun 30, 2025 6.97 Mn
Mar 31, 2025 4.48 Mn
Dec 31, 2024 9.32 Mn
Sep 30, 2024 14.26 Mn
Jun 30, 2024 1.73 Mn
Dec 31, 2023 3.00 Mn
API Access

Actuate Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=ACTU&period=max&api_key=YOUR_API_KEY